Olfactory system pathology as a model of Lewy neurodegenerative disease

Journal of the Neurological Sciences

Volumn 289, Issue 1-2, 2010, Pages 49-54

  Duda, John E ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Lewy bodies; Neurodegeneration; Olfaction; Parkinson's disease; Pathophysiology

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BRAIN REGION; DEGENERATIVE DISEASE; DEMENTIA; DENDRITIC CELL; DIFFUSE LEWY BODY DISEASE; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN CELL; LEWY BODY; LIFE; NERVE FIBER; NERVOUS SYSTEM; NEUROANATOMY; NEUROPATHOLOGY; OLFACTORY BULB; OLFACTORY SYSTEM; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SOMATIC CELL; SYMPTOM; SYNAPSE;

ANIMALS; HUMANS; LEWY BODIES; NEURITIS; NEURODEGENERATIVE DISEASES; NEURONS; OLFACTION DISORDERS; OLFACTORY PATHWAYS;

EID: 74149090746     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.08.042     Document Type: Article

References (41)

1. Hawkes C.H., Shephard B.C., and Daniel S.E. Olfactory dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatry 62 (1997) 436-446
2. Doty R.L., Deems D.A., and Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38 (1988) 1237-1244
3. Hower R.E., Rick J.H., Balderston C.C., Weintraub D., Sidenvall B., Stern M.B., et al. Olfactory dysfunction and Parkinson's disease progression. Neurology 70 (2008) A397
4. Kratskin I.L., and Belluzzi O. Anatomy and neurochemistry of the olfactory bulb. In: Doty R.L. (Ed). Handbook of olfaction and gustation (2003), Marcel Dekker, New York 235-276
5. Shepherd G.M., and Greer C.A. Olfactory bulb. In: Shepherd G.M. (Ed). The synaptic organization of the brain (1997), Oxford University Press, New York 159-203
6. Duda J.E., Shah U., Arnold S.E., Lee V.M., and Trojanowski J.Q. The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases. Exp Neurol 160 (1999) 515-522
7. Daniel S.E., and Hawkes C.H. Preliminary diagnosis of Parkinson's disease by olfactory bulb pathology. Lancet 340 (1992) 186
8. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 (1997) 2045-2047
9. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., and Goedert M. Alpha-synuclein in Lewy bodies. Nature 388 (1997) 839-840
10. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., and Goedert M. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci U S A 95 (1998) 6469-6473
11. Beach T.G., White III C.L., Hladik C.L., Sabbagh M.N., Connor D.J., Shill H.A., et al. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol 117 (2009) 169-174
12. Tsuboi Y., Wszolek Z.K., Graff-Radford N.R., Cookson N., and Dickson D.W. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4. Neuropathol Appl Neurobiol 29 (2003) 503-510
13. Duda J.E., Giasson B.I., Mabon M.E., Miller D.C., Golbe L.I., Lee V.M., et al. Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred. Acta Neuropathol (Berl) 104 (2002) 7-11
14. Frasier M., and Wolozin B. Following the leader: fibrillization of alpha-synuclein and tau. Exp Neurol 187 (2004) 235-239
15. Lee V.M., Giasson B.I., and Trojanowski J.Q. More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases. Trends Neurosci 27 (2004) 129-134
16. Braak H., Del Tredici K., Bratzke H., Hamm-Clement J., Sandmann-Keil D., and Rub U. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol 249 Suppl 3 (2002) III/1-III/5
17. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., and Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24 (2003) 197-211
18. Lerner A., and Bagic A. Olfactory pathogenesis of idiopathic Parkinson disease revisited. Mov Disord 23 (2008) 1076-1084
19. Hawkes C.H., Del Tredici K., and Braak H. Parkinson's disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol 33 (2007) 599-614
20. Pearce R.K., Hawkes C.H., and Daniel S.E. The anterior olfactory nucleus in Parkinson's disease. Mov Disord 10 (1995) 283-287
21. Silveira-Moriyama L., Holton J., Kingsbury A., Ayling H., Petrie A., Sterlacci W., et al. Regional differences in the severity of Lewy body pathology across the olfactory cortex. Neurosic Lett 453 (2009) 77-80
22. Hoogland P.V., van den B.R., and Huisman E. Misrouted olfactory fibres and ectopic olfactory glomeruli in normal humans and in Parkinson and Alzheimer patients. Neuropathol Appl Neurobiol 29 (2003) 303-311
23. Huisman E., Uylings H.B., and Hoogland P.V. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease. Mov Disord 19 (2004) 687-692
24. Huisman E., Uylings H.B., and Hoogland P.V. Gender-related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson's disease patients. Mov Disord 23 (2008) 1407-1413
25. Smeets W.J., and Gonzalez A. Catecholamine systems in the brain of vertebrates: new perspectives through a comparative approach. Brain Res Brain Res Rev 33 (2000) 308-379
26. Van Den Eeden S.K., Tanner C.M., Bernstein A.L., Fross R.D., Leimpeter A., Bloch D.A., et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157 (2003) 1015-1022
27. Shulman L.M. Gender differences in Parkinson's disease. Gend Med 4 (2007) 8-18
28. Bedard A., and Parent A. Evidence of newly generated neurons in the human olfactory bulb. Brain Res Dev Brain Res 151 (2004) 159-168
29. Liu Z., and Martin L.J. Olfactory bulb core is a rich source of neural progenitor and stem cells in adult rodent and human. J Comp Neurol 459 (2003) 368-391
30. Höglinger G.U., Rizk P., Muriel M.P., Duyckaerts C., Oertel W.H., Caille I., et al. Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci 7 (2004) 726-735
31. Doty R.L., Golbe L.I., McKeown D.A., Stern M.B., Lehrach C.M., and Crawford D. Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease. Neurology 43 (1993) 962-965
32. Wenning G.K., Shephard B., Hawkes C., Petruckevitch A., Lees A., and Quinn N. Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand 91 (1995) 247-250
33. Busenbark K.L., Huber S.J., Greer G., Pahwa R., and Koller W.C. Olfactory function in essential tremor. Neurology 42 (1992) 1631-1632
34. Louis E.D., Bromley S.M., Jurewicz E.C., and Watner D. Olfactory dysfunction in essential tremor: a deficit unrelated to disease duration or severity. Neurology 59 (2002) 1631-1633
35. Doty R.L., Singh A., Tetrud J., and Langston J.W. Lack of major olfactory dysfunction in MPTP-induced parkinsonism. Ann Neurol 32 (1992) 97-100
36. Stern M.B., Doty R.L., Dotti M., Corcoran P., Crawford D., McKeown D.A., et al. Olfactory function in Parkinson's disease subtypes. Neurology 44 (1994) 266-268
37. Ondo W.G., and Lai D. Olfaction testing in patients with tremor-dominant Parkinson's disease: is this a distinct condition?. Mov Disord 20 (2005) 471-475
38. Duda J.E. Pathology and neurotransmitter abnormalities of dementia with Lewy bodies. Dement Geriatr Cogn Disord 17 Suppl 1 (2004) 3-14
39. Duda J.E., Giasson B.I., Lee V.M.-Y., and Trojanowski J.Q. Is the initial insult in Parkinson's disease and dementia with Lewy bodies a neuritic dystrophy?. Ann NY Acad Sci 991 (2003) 295-297
40. Braak H., Rub U., Gai W.P., and Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110 (2003) 517-536
41. Duda J.E., Giasson B.I., Mabon M.E., Lee V.M., and Trojanowski J.Q. Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann Neurol 52 (2002) 205-210